CRISM' Therapeutics Corp recorded a single purchase by Non-Executive Director Gerald Beaney on June 3, 2024. This individual acquired 25,000 shares for a total value of 2,316.25 dollars. No further insider trading activity has been reported since that date, which occurred more than three months ago.